Logo image of KRMD

KORU MEDICAL SYSTEMS INC (KRMD) Stock Fundamental Analysis

USA - NASDAQ:KRMD - US7599101026 - Common Stock

4.02 USD
-0.14 (-3.37%)
Last: 9/22/2025, 4:30:02 PM
4.02 USD
0 (0%)
After Hours: 9/22/2025, 4:30:02 PM
Fundamental Rating

3

KRMD gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 190 industry peers in the Health Care Equipment & Supplies industry. The financial health of KRMD is average, but there are quite some concerns on its profitability. While showing a medium growth rate, KRMD is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year KRMD has reported negative net income.
In the past year KRMD has reported a negative cash flow from operations.
In the past 5 years KRMD always reported negative net income.
KRMD had a negative operating cash flow in each of the past 5 years.
KRMD Yearly Net Income VS EBIT VS OCF VS FCFKRMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

KRMD has a Return On Assets (-17.69%) which is comparable to the rest of the industry.
KRMD's Return On Equity of -27.32% is in line compared to the rest of the industry. KRMD outperforms 58.95% of its industry peers.
Industry RankSector Rank
ROA -17.69%
ROE -27.32%
ROIC N/A
ROA(3y)-30.34%
ROA(5y)-21.02%
ROE(3y)-43.74%
ROE(5y)-29.41%
ROIC(3y)N/A
ROIC(5y)N/A
KRMD Yearly ROA, ROE, ROICKRMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

The Gross Margin of KRMD (63.15%) is better than 64.21% of its industry peers.
In the last couple of years the Gross Margin of KRMD has remained more or less at the same level.
KRMD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 63.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.65%
GM growth 5Y-0.23%
KRMD Yearly Profit, Operating, Gross MarginsKRMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

5

2. Health

2.1 Basic Checks

KRMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
KRMD has more shares outstanding than it did 1 year ago.
KRMD has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, KRMD has an improved debt to assets ratio.
KRMD Yearly Shares OutstandingKRMD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
KRMD Yearly Total Debt VS Total AssetsKRMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

An Altman-Z score of 12.51 indicates that KRMD is not in any danger for bankruptcy at the moment.
KRMD has a Altman-Z score of 12.51. This is amongst the best in the industry. KRMD outperforms 92.63% of its industry peers.
KRMD has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
KRMD's Debt to Equity ratio of 0.01 is fine compared to the rest of the industry. KRMD outperforms 71.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 12.51
ROIC/WACCN/A
WACC8.78%
KRMD Yearly LT Debt VS Equity VS FCFKRMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 2.91 indicates that KRMD has no problem at all paying its short term obligations.
KRMD's Current ratio of 2.91 is in line compared to the rest of the industry. KRMD outperforms 57.89% of its industry peers.
A Quick Ratio of 2.25 indicates that KRMD has no problem at all paying its short term obligations.
With a Quick ratio value of 2.25, KRMD perfoms like the industry average, outperforming 57.37% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.91
Quick Ratio 2.25
KRMD Yearly Current Assets VS Current LiabilitesKRMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

5

3. Growth

3.1 Past

KRMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.00%, which is quite impressive.
Looking at the last year, KRMD shows a quite strong growth in Revenue. The Revenue has grown by 19.57% in the last year.
Measured over the past years, KRMD shows a small growth in Revenue. The Revenue has been growing by 7.76% on average per year.
EPS 1Y (TTM)20%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)19.57%
Revenue growth 3Y12.72%
Revenue growth 5Y7.76%
Sales Q2Q%20.94%

3.2 Future

Based on estimates for the next years, KRMD will show a very strong growth in Earnings Per Share. The EPS will grow by 32.12% on average per year.
Based on estimates for the next years, KRMD will show a quite strong growth in Revenue. The Revenue will grow by 16.30% on average per year.
EPS Next Y20.95%
EPS Next 2Y31.71%
EPS Next 3Y32.12%
EPS Next 5YN/A
Revenue Next Year18.53%
Revenue Next 2Y17.44%
Revenue Next 3Y16.3%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
KRMD Yearly Revenue VS EstimatesKRMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
KRMD Yearly EPS VS EstimatesKRMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.05 -0.1 -0.15 -0.2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

KRMD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for KRMD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KRMD Price Earnings VS Forward Price EarningsKRMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100 -150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KRMD Per share dataKRMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

KRMD's earnings are expected to grow with 32.12% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.71%
EPS Next 3Y32.12%

More info and screens

0

5. Dividend

5.1 Amount

KRMD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KORU MEDICAL SYSTEMS INC

NASDAQ:KRMD (9/22/2025, 4:30:02 PM)

After market: 4.02 0 (0%)

4.02

-0.14 (-3.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)N/A N/A
Inst Owners52.7%
Inst Owner ChangeN/A
Ins Owners7.65%
Ins Owner Change0.68%
Market Cap185.84M
Analysts80
Price Target5.71 (42.04%)
Short Float %2.76%
Short Ratio10.35
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)62.29%
Min EPS beat(2)24.59%
Max EPS beat(2)100%
EPS beat(4)4
Avg EPS beat(4)37.77%
Min EPS beat(4)3.88%
Max EPS beat(4)100%
EPS beat(8)8
Avg EPS beat(8)40.05%
EPS beat(12)12
Avg EPS beat(12)34.3%
EPS beat(16)15
Avg EPS beat(16)29.18%
Revenue beat(2)2
Avg Revenue beat(2)6.08%
Min Revenue beat(2)5.66%
Max Revenue beat(2)6.5%
Revenue beat(4)3
Avg Revenue beat(4)3.5%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)6.5%
Revenue beat(8)6
Avg Revenue beat(8)2.35%
Revenue beat(12)7
Avg Revenue beat(12)1.68%
Revenue beat(16)11
Avg Revenue beat(16)2.34%
PT rev (1m)1.82%
PT rev (3m)1.82%
EPS NQ rev (1m)-7.69%
EPS NQ rev (3m)-75%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.59%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.47%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.04
P/FCF N/A
P/OCF N/A
P/B 11.25
P/tB 11.74
EV/EBITDA N/A
EPS(TTM)-0.08
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.8
BVpS0.36
TBVpS0.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.69%
ROE -27.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 63.15%
FCFM N/A
ROA(3y)-30.34%
ROA(5y)-21.02%
ROE(3y)-43.74%
ROE(5y)-29.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.65%
GM growth 5Y-0.23%
F-Score5
Asset Turnover1.44
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 177.3%
Cap/Sales 4.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.91
Quick Ratio 2.25
Altman-Z 12.51
F-Score5
WACC8.78%
ROIC/WACCN/A
Cap/Depr(3y)239.72%
Cap/Depr(5y)210.83%
Cap/Sales(3y)5.63%
Cap/Sales(5y)4.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y20.95%
EPS Next 2Y31.71%
EPS Next 3Y32.12%
EPS Next 5YN/A
Revenue 1Y (TTM)19.57%
Revenue growth 3Y12.72%
Revenue growth 5Y7.76%
Sales Q2Q%20.94%
Revenue Next Year18.53%
Revenue Next 2Y17.44%
Revenue Next 3Y16.3%
Revenue Next 5YN/A
EBIT growth 1Y32.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year83.93%
EBIT Next 3Y41.31%
EBIT Next 5YN/A
FCF growth 1Y67.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y87.78%
OCF growth 3YN/A
OCF growth 5YN/A